Can-Fite BioPharma (CANF) Prepaid Assets (2016 - 2026)
Can-Fite BioPharma (CANF) posted Prepaid Assets of $960000.0 for Q2 2026, up 6.67% quarter-over-quarter from $900000.0 in Q4 2025, and down 17.81% YoY from $1.2 million in Q2 2025.
Analysis
Can-Fite BioPharma (CANF) Prepaid Assets (2016 - 2026) Analysis & Trends
Can-Fite BioPharma (CANF) has 11 years of Prepaid Assets data on file, last reported at $960000.0 in Q2 2026.
- For the quarter ending Q2 2026, Prepaid Assets fell 17.81% year-over-year to $960000.0; the trailing twelve-month figure through Jun 2026 stood at $960000.0 (down 17.81% YoY), and the FY2025 full-year result was $900000.0, down 17.81% from the prior year.
- Prepaid Assets was $960000.0 for Q2 2026 at Can-Fite BioPharma, up from $900000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.8 million in Q2 2022 to a low of $900000.0 in Q4 2025.
- A 5-year average of $1.2 million and a median of $1.1 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 116.03% in 2022 and tumbled 35.96% in 2023, its largest moves.
- Can-Fite BioPharma's Prepaid Assets stood at $1.2 million in 2022, then decreased by 15.73% to $986000.0 in 2023, then increased by 11.05% to $1.1 million in 2024, then dropped by 17.81% to $900000.0 in 2025, then gained by 6.67% to $960000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $960000.0 in Q2 2026, $900000.0 in Q4 2025, and $1.2 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.12 Bn | 628.36 Bn | 17.26 Bn |
| 2 | AbbVie | 445.86 Bn | 439.29 Bn | 12.70 Bn |
| 3 | Merck | 362.13 Bn | 354.99 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.88 Bn | 261.19 Bn | 11.24 Bn |
| 5 | Pfizer | 156.96 Bn | 145.26 Bn | 10.94 Bn |
| 6 | Sanofi | 52.26 Bn | 44.88 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 42.98 Bn | 42.98 Bn | - |
| 8 | Incyte | 25.13 Bn | 20.59 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.56 Bn | 18.90 Bn | 683.80 Mn |
| 10 | Can-Fite BioPharma | 1.80 Mn | -1.19 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 960,000.00 |
| Dec 31, 2025 | 900,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Dec 31, 2023 | 986,000.00 |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.29 Mn |
| Mar 31, 2023 | 962,000.00 |
| Dec 31, 2022 | 1.17 Mn |
| Sep 30, 2022 | 1.75 Mn |
| Jun 30, 2022 | 1.82 Mn |
| Mar 31, 2022 | 971,000.00 |
| Dec 31, 2021 | 929,000.00 |
| Sep 30, 2021 | 811,000.00 |
| Jun 30, 2021 | 1.75 Mn |
| Mar 31, 2021 | 1.02 Mn |
| Dec 31, 2020 | 1.06 Mn |
| Jun 30, 2020 | 3.57 Mn |
| Dec 31, 2019 | 4.38 Mn |